Regulations.gov document
Microbiology Devices; Reclassification of Certain Hepatitis C Virus Antibody Assays…
Proposed Rule · FDA-2020-N-1082 · posted Apr 2, 2020
Key facts
| Document ID | FDA-2020-N-1082-0001 |
|---|---|
| Title | Microbiology Devices; Reclassification of Certain Hepatitis C Virus Antibody Assays Devices, To Be Renamed Hepatitis C Virus Antibody Tests |
| Document type | Proposed Rule |
| Subtype | Amendment |
| Agency | FDA |
| Docket | FDA-2020-N-1082 |
| Posted | Apr 2, 2020 |
| Federal Register citation | 85 FR 18490 |
| FR document number | 2020-06821 |
| CFR | 21 CFR Part 866 |
| Comment period opens | Apr 2, 2020 |
| Comments due | Jun 2, 2020 |
| Effective date | Apr 2, 2020 |
At a glance
- 1–9 Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: